Patent details

EP2193196 Title: ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

Basic Information

Publication number:
EP2193196
PCT Application Number:
PCT/US/2008/078014
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP088341367
PCT Publication Number:
WO/2009/042962
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
French Title of Invention:
ANTIDOTES POUR LES INHIBITEURS DU FACTEUR XA ET LEUR PROCÉDÉ D'UTILISATION
German Title of Invention:
GEGENMITTEL FÜR FAKTOR-XA-HEMMER UND VERWENDUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
26/09/2008
Grant date:
13/07/2016
EP Publication Date:
13/07/2016
PCT Publication Date:
02/04/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/06/2010
EP B1 Publication Date:
13/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/09/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/01/2021
 
 

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, MA 02210, Boston, United States (US)

History of Owners

From:
26/09/2008
To:
28/01/2021

Name:
Portola Pharmaceuticals Inc.
Address:
270 East Grand Avenue Suite 22, South San Francisco California 94080, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
11/10/2016
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
LU Genmin
Address:
United States (US)

2

Name:
ANDRE Patrick
Address:
United States (US)

3

Name:
SINHA Uma
Address:
United States (US)

4

Name:
PHILLIPS David R.
Address:
United States (US)

Priority

1

Priority Number:
976343 P
Priority Date:
28/09/2007
Priority Country:
United States (US)

2

Priority Number:
90574 P
Priority Date:
20/08/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000042A
Date Registered:
28/01/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
STOLMÁR & PARTNER
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, MA 02210, Boston, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/09/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
28/01/2021 Request For Change 15
03/02/2021 Outgoing Correspondence 1